Chinetti-Gbaguidi G, Copin C, Derudas B, Marx N, Eechkoute J, Staels B
Inserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France; CHU, CNRS, Inserm, IRCAN, Université Côte d'Azur, Nice, France.
Inserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France.
PPAR Res. 2016;2016:2756781. doi: 10.1155/2016/2756781. Epub 2016 Dec 27.
Tissue factor (TF) is the initiator of the blood coagulation cascade after interaction with the activated factor VII (FVIIa). Moreover, the TF/FVIIa complex also activates intracellular signalling pathways leading to the production of inflammatory cytokines. The TF/FVIIa complex is inhibited by the tissue factor pathway inhibitor-1 (TFPI-1). Peroxisome proliferator-activated receptor gamma (PPAR) is a transcription factor that, together with PPAR and PPAR/, controls macrophage functions. However, whether PPAR activation modulates the expression of TFP1-1 in human macrophages is not known. Here we report that PPAR activation increases the expression of TFPI-1 in human macrophages in vitro as well as in vivo in circulating peripheral blood mononuclear cells. The induction of TFPI-1 expression by PPAR ligands, an effect shared by the activation of PPAR and PPAR/, occurs also in proinflammatory M1 and in anti-inflammatory M2 polarized macrophages. As a functional consequence, treatment with PPAR ligands significantly reduces the inflammatory response induced by FVIIa, as measured by variations in the IL-8, MMP-2, and MCP-1 expression. These data identify a novel role for PPAR in the control of TF the pathway.
组织因子(TF)与活化的因子VII(FVIIa)相互作用后,是血液凝固级联反应的启动因子。此外,TF/FVIIa复合物还激活细胞内信号通路,导致炎性细胞因子的产生。TF/FVIIa复合物受组织因子途径抑制剂-1(TFPI-1)抑制。过氧化物酶体增殖物激活受体γ(PPAR)是一种转录因子,它与PPAR和PPAR一起控制巨噬细胞功能。然而,PPAR激活是否调节人巨噬细胞中TFP1-1的表达尚不清楚。在此我们报告,PPAR激活在体外人巨噬细胞以及体内循环外周血单核细胞中增加TFPI-1的表达。PPAR配体对TFPI-1表达的诱导作用,PPAR和PPAR激活也具有这种作用,在促炎性M1和抗炎性M2极化巨噬细胞中也会发生。作为一种功能结果,用PPAR配体处理可显著降低FVIIa诱导的炎症反应,这通过IL-8、MMP-2和MCP-1表达的变化来衡量。这些数据确定了PPAR在控制TF途径中的新作用。